563 related articles for article (PubMed ID: 26407715)
1. Circulating leptin in non-alcoholic fatty liver disease: a systematic review and meta-analysis.
Polyzos SA; Aronis KN; Kountouras J; Raptis DD; Vasiloglou MF; Mantzoros CS
Diabetologia; 2016 Jan; 59(1):30-43. PubMed ID: 26407715
[TBL] [Abstract][Full Text] [Related]
2. Circulating retinol binding protein 4 levels in nonalcoholic fatty liver disease: a systematic review and meta-analysis.
Zhou Z; Chen H; Ju H; Sun M
Lipids Health Dis; 2017 Sep; 16(1):180. PubMed ID: 28931435
[TBL] [Abstract][Full Text] [Related]
3. Circulating tumor necrosis factor-α levels in non-alcoholic fatty liver disease: A systematic review and a meta-analysis.
Potoupni V; Georgiadou M; Chatzigriva E; Polychronidou G; Markou E; Zapantis Gakis C; Filimidou I; Karagianni M; Anastasilakis D; Evripidou K; Ftergioti A; Togkaridou M; Tsaftaridis N; Apostolopoulos A; Polyzos SA
J Gastroenterol Hepatol; 2021 Nov; 36(11):3002-3014. PubMed ID: 34289181
[TBL] [Abstract][Full Text] [Related]
4. Association of serum ferritin with non-alcoholic fatty liver disease: a meta-analysis.
Du SX; Lu LL; Geng N; Victor DW; Chen LZ; Wang C; Yue HY; Xin YN; Xuan SY; Jin WW
Lipids Health Dis; 2017 Dec; 16(1):228. PubMed ID: 29197393
[TBL] [Abstract][Full Text] [Related]
5. Circulating leptin in patients with nonalcoholic fatty liver disease-related liver fibrosis: a systematic review and a meta-analysis.
Makri ES; Evripidou K; Polyzos SA
J Gastroenterol Hepatol; 2024 May; 39(5):806-817. PubMed ID: 38238084
[TBL] [Abstract][Full Text] [Related]
6. Circulating Ferritin in Patients with Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-analysis.
Makri E; Orfanidou M; Makri ES; Goulas A; Terpos E; Polyzos SA
J Clin Exp Hepatol; 2024; 14(3):101353. PubMed ID: 38435724
[TBL] [Abstract][Full Text] [Related]
7. Non-alcoholic Fatty Liver Disease in Morbidly Obese Individuals Undergoing Bariatric Surgery: Prevalence and Effect of the Pre-Bariatric Very Low Calorie Diet.
Schwenger KJP; Fischer SE; Jackson TD; Okrainec A; Allard JP
Obes Surg; 2018 Apr; 28(4):1109-1116. PubMed ID: 29098545
[TBL] [Abstract][Full Text] [Related]
8. Circulating chemerin levels in metabolic-associated fatty liver disease: a systematic review and meta-analysis.
Ren Q; Wang H; Zeng Y; Fang X; Wang M; Li D; Huang W; Xu Y
Lipids Health Dis; 2022 Mar; 21(1):27. PubMed ID: 35236351
[TBL] [Abstract][Full Text] [Related]
9. Increased serum soluble lectin-like oxidized low-density lipoprotein receptor-1 levels in patients with biopsy-proven nonalcoholic fatty liver disease.
Ozturk O; Colak Y; Senates E; Yilmaz Y; Ulasoglu C; Doganay L; Ozkanli S; Oltulu YM; Coskunpinar E; Tuncer I
World J Gastroenterol; 2015 Jul; 21(26):8096-102. PubMed ID: 26185381
[TBL] [Abstract][Full Text] [Related]
10. Increased Circulating Levels of Alpha-Ketoglutarate in Morbidly Obese Women with Non-Alcoholic Fatty Liver Disease.
Aragonès G; Auguet T; Berlanga A; Guiu-Jurado E; Martinez S; Armengol S; Sabench F; Ras R; Hernandez M; Aguilar C; Colom J; Sirvent JJ; Del Castillo D; Richart C
PLoS One; 2016; 11(4):e0154601. PubMed ID: 27123846
[TBL] [Abstract][Full Text] [Related]
11. Circulating lipidomic alterations in obese and non-obese subjects with non-alcoholic fatty liver disease.
Jung Y; Lee MK; Puri P; Koo BK; Joo SK; Jang SY; Lee DH; Jung YJ; Kim BG; Lee KL; Park TS; Kang KT; Ryu DH; Kang SW; Kim D; Oh S; Kim W; Hwang GS
Aliment Pharmacol Ther; 2020 Nov; 52(10):1603-1614. PubMed ID: 32892365
[TBL] [Abstract][Full Text] [Related]
12. Elevated plasma copeptin levels identify the presence and severity of non-alcoholic fatty liver disease in obesity.
Barchetta I; Enhörning S; Cimini FA; Capoccia D; Chiappetta C; Di Cristofano C; Silecchia G; Leonetti F; Melander O; Cavallo MG
BMC Med; 2019 Apr; 17(1):85. PubMed ID: 31035998
[TBL] [Abstract][Full Text] [Related]
13. Bariatric Surgery Reduces Features of Nonalcoholic Steatohepatitis in Morbidly Obese Patients.
Lassailly G; Caiazzo R; Buob D; Pigeyre M; Verkindt H; Labreuche J; Raverdy V; Leteurtre E; Dharancy S; Louvet A; Romon M; Duhamel A; Pattou F; Mathurin P
Gastroenterology; 2015 Aug; 149(2):379-88; quiz e15-6. PubMed ID: 25917783
[TBL] [Abstract][Full Text] [Related]
14. Prevalence and risk factors for biopsy-proven non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in a prospective cohort of adult patients with gallstones.
García-Monzón C; Vargas-Castrillón J; Porrero JL; Alonso MT; Bonachía O; Castillo MJ; Marcos A; Quirós E; Ramos B; Sánchez-Cabezudo C; Villar S; Sáez A; Rodríguez de Cía J; del Pozo E; Vega-Piris L; Soto-Fernández S; Lo Iacono O; Miquilena-Colina ME
Liver Int; 2015 Aug; 35(8):1983-91. PubMed ID: 25708133
[TBL] [Abstract][Full Text] [Related]
15. Liver fat deposition and mitochondrial dysfunction in morbid obesity: An approach combining metabolomics with liver imaging and histology.
Calvo N; Beltrán-Debón R; Rodríguez-Gallego E; Hernández-Aguilera A; Guirro M; Mariné-Casadó R; Millá L; Alegret JM; Sabench F; del Castillo D; Vinaixa M; Rodríguez MÀ; Correig X; García-Álvarez R; Menendez JA; Camps J; Joven J
World J Gastroenterol; 2015 Jun; 21(24):7529-44. PubMed ID: 26140000
[TBL] [Abstract][Full Text] [Related]
16. How adiponectin, leptin, and ghrelin orchestrate together and correlate with the severity of nonalcoholic fatty liver disease.
Machado MV; Coutinho J; Carepa F; Costa A; Proença H; Cortez-Pinto H
Eur J Gastroenterol Hepatol; 2012 Oct; 24(10):1166-72. PubMed ID: 22735605
[TBL] [Abstract][Full Text] [Related]
17. Circulating angiopoietin-like proteins in metabolic-associated fatty liver disease: a systematic review and meta-analysis.
Ke Y; Liu S; Zhang Z; Hu J
Lipids Health Dis; 2021 May; 20(1):55. PubMed ID: 34034750
[TBL] [Abstract][Full Text] [Related]
18. Prevalence and Predictors of Non-Alcoholic Fatty Liver Disease in Morbidly Obese South Indian Patients Undergoing Bariatric Surgery.
Praveenraj P; Gomes RM; Kumar S; Karthikeyan P; Shankar A; Parthasarathi R; Senthilnathan P; Rajapandian S; Palanivelu C
Obes Surg; 2015 Nov; 25(11):2078-87. PubMed ID: 25835982
[TBL] [Abstract][Full Text] [Related]
19. Prevalence of biopsy-proven non-alcoholic fatty liver disease in severely obese subjects without metabolic syndrome.
Qureshi K; Abrams GA
Clin Obes; 2016 Apr; 6(2):117-23. PubMed ID: 26856683
[TBL] [Abstract][Full Text] [Related]
20. Circulating microRNA signature in non-alcoholic fatty liver disease: from serum non-coding RNAs to liver histology and disease pathogenesis.
Pirola CJ; Fernández Gianotti T; Castaño GO; Mallardi P; San Martino J; Mora Gonzalez Lopez Ledesma M; Flichman D; Mirshahi F; Sanyal AJ; Sookoian S
Gut; 2015 May; 64(5):800-12. PubMed ID: 24973316
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
